Artivion Inc. (CRY)
NYSE: CRY
· Real-Time Price · USD
17.88
0.25 (1.42%)
At close: Jan 24, 2022, 6:00 AM
Artivion Revenue Breakdown
| Period Ending | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Jun 30, 2020 |
|---|---|---|---|---|
| Aortic Stent Grafts Revenue | 20.9M | 21.06M | 20.2M | 10.12M |
| Aortic Stent Grafts Revenue Growth | -0.80% | +4.25% | +99.73% | n/a |
| On X Revenue | 14.02M | 14.73M | 13.1M | n/a |
| On X Revenue Growth | -4.78% | +12.46% | n/a | n/a |
| Other Products Revenue | 1.65M | 2.42M | 2.22M | n/a |
| Other Products Revenue Growth | -32.08% | +9.25% | n/a | n/a |
| Preservation Services Revenue | 19.1M | 20.07M | 17.74M | n/a |
| Preservation Services Revenue Growth | -4.84% | +13.13% | n/a | n/a |
| Surgical Sealants Revenue | 16.54M | 17.86M | 17.83M | n/a |
| Surgical Sealants Revenue Growth | -7.39% | +0.20% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 51.25M | 39.05M | 40.83M | 38.64M | 36.1M | 33.74M | 32.29M | 39M | 37.61M | 34.26M | 34.62M | 36.52M | 35.63M | 32.87M | 34.73M | 37.35M | 30.2M | 24.76M | 23.39M | 22.87M | 22.25M | 20.59M | 22.44M | 26.27M | 19.14M | 17.49M | 19.33M | 18.97M |
| Selling, General, and Administrative Revenue Growth | +31.24% | -4.35% | +5.67% | +7.02% | +6.99% | +4.51% | -17.21% | +3.70% | +9.78% | -1.05% | -5.19% | +2.50% | +8.39% | -5.34% | -7.02% | +23.69% | +21.97% | +5.84% | +2.26% | +2.81% | +8.03% | -8.22% | -14.61% | +37.28% | +9.40% | -9.48% | +1.89% | n/a |
| Research and Development Revenue | 9.46M | 9.97M | 8.36M | 7.75M | 6.57M | 5.75M | 5.52M | 6.36M | 5.31M | 6.26M | 5.84M | 5.55M | 6.78M | 5.22M | 5.72M | 5.37M | 6.36M | 4.28M | 4.73M | 4.09M | 3.84M | 3.71M | 3.28M | 2.61M | 2.54M | 2.96M | 2.68M | 2.25M |
| Research and Development Revenue Growth | -5.13% | +19.28% | +7.82% | +17.95% | +14.23% | +4.22% | -13.12% | +19.65% | -15.13% | +7.16% | +5.28% | -18.22% | +29.84% | -8.64% | +6.50% | -15.61% | +48.77% | -9.54% | +15.51% | +6.48% | +3.50% | +13.27% | +25.68% | +2.72% | -14.19% | +10.28% | +19.18% | n/a |